Clinical effectiveness and cost-utility analysis of phosphate binders for treating hyperphosphatemia in end-stage renal disease patients : a multicenter real-world study
Uncontrolled hyperphosphatemia in end-stage renal disease (ESRD) patients increases the risk of cardiovascular disease (CVD), bone disorders, and mortality. Phosphate binders (PBs) are recommended as a treatment option. Calcium-based PBs (CBPBs) had significantly higher all-cause mortality rates compared to non-calcium...